Expert System for Automatic Analysis of Data Quality in Clinical Trials

In the framework of the development scheme 'Central Innovation Scheme for Medium-sized Businesses' of the German Federal Ministry for Economics and Technology (BMWI), clinIT AG, based in Freiburg, Germany, has been awarded a six-figure federal grant in cooperation with the Institute for Informatics of the Albert-Ludwigs-University Freiburg, Faculty for Data Bases and Information Systems.

The IT company, clinIT, intends to develop a novel tool for automatic analysis of data quality in all types of clinical studies. Up to now, such analyses had to be carried out individually for each project via the application programming. On the basis of rules, this new tool will formalize this process and make automatic processing accessible.

For the first time now, this innovation will give project and data managers with no specific programming skills the means to measure and control the quality of data and processes over large-volume study libraries/data bases. The data quality is crucial in a clinical trial, in order to be able to reach accurate and reliable conclusions on the safety and efficacy of the test medication. The new development of clinIT and the Freiburg Institute for Informatics represents not only a decisive advance from the perspective of cost-effectiveness, but especially also in terms of the patient's well-being.

For further information, please visit:
http://www.clinit.net

About clinIT AG
Founded in 2001, clinIT AG is a specialist for clinical information technology whose core business is the development and supply of information systems for both data entry and management of clinical trial data as well as providing support for the process flow in clinical studies. The latter involves systems for data capture, patient randomization and disease management. Further services include statistics, data management and medical consulting. For more information, please visit www.clinit.net.

About the Institute for Informatics of the Albert-Ludwigs-University Freiburg, Faculty for Data Bases and Information Systems
The Institute for Informatics was founded in 1995 and belongs to the Faculty of Applied Sciences of the University. The Faculty for Data Bases and Information Systems has special expertise in the sector of rule-based languages, work flow management systems and internet-based technologies, especially information extraction and integration. Current research projects concern also memory systems for the semantic web and the analysis of correspondingly based query languages. For more information, please visit www.informatik.uni-freiburg.de/.

Most Popular Now

Time-restricted eating reshapes gene expression th…

Numerous studies have shown health benefits of time-restricted eating including increase in life span in laboratory studies, making practices like intermittent fasting a ...

Incurable liver disease may prove curable

Research led by Associate Professor Duc Dong, Ph.D., has shown for the first time that the effects of Alagille syndrome, an incurable genetic disorder that affects the li...

Scientists develop a cancer vaccine to simultaneou…

Scientists are harnessing a new way to turn cancer cells into potent, anti-cancer agents. In the latest work from the lab of Khalid Shah, MS, PhD, at Brigham and Women’s ...

AstraZeneca to acquire CinCor Pharma to strengthen…

AstraZeneca has entered into a definitive agreement to acquire CinCor Pharma, Inc. (CinCor), a US-based clinical-stage biopharmaceutical company, focused on developing no...

NextPoint Therapeutics announces $80 million Serie…

NextPoint Therapeutics, a biotechnology company developing a new world of precision immuno-oncology, announced today that it raised $80 million in Series B financing co-l...

COVID-19 vaccines, prior infection reduce transmis…

Vaccination and boosting, especially when recent, helped to limit the spread of COVID-19 in California prisons during the first Omicron wave, according to an analysis by ...

Bayer to accelerate drug discovery with Google Clo…

Bayer AG and Google Cloud announced a collaboration to drive early drug discovery that will apply Google Cloud's Tensor Processing Units (TPUs), which are custom-develope...

Study identifies potential new approach for treati…

Targeting iron metabolism in immune system cells may offer a new approach for treating systemic lupus erythematosus (SLE) - the most common form of the chronic autoimmune...

Nanotechnology may improve gene therapy for blindn…

Using nanotechnology that enabled mRNA-based COVID-19 vaccines, a new approach to gene therapy may improve how physicians treat inherited forms of blindness. A collabo...

Acquisition of Neogene Therapeutics completed

AstraZeneca has completed the acquisition of Neogene Therapeutics Inc. (Neogene), a global clinical-stage biotechnology company pioneering the discovery, development and ...

Modified CRISPR-based enzymes improve the prospect…

Many genetic diseases are caused by diverse mutations spread across an entire gene, and designing genome editing approaches for each patient’s mutation would be impractic...

Pfizer expands 'An Accord for a Healthier World' p…

Pfizer Inc. (NYSE: PFE) announced that it has significantly expanded its commitment to An Accord for a Healthier World to offer the full portfolio of medicines and vaccin...